Hostname: page-component-7b7567c8c-48dgx Total loading time: 0 Render date: 2026-11-18T03:40:43.195Z Has data issue: false hasContentIssue false

A model-based study to estimate the health and economic impact of health technology assessment in Thailand

Published online by Cambridge University Press:  04 May 2022

Pritaporn Kingkaew
Affiliation:
Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
Nuttakarn Budtarad
Affiliation:
Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
Sarayuth Khuntha
Affiliation:
Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
Euan Barlow
Affiliation:
Department of Management Science, Strathclyde Business School, University of Strathclyde, Glasgow, United Kingdom
Alec Morton
Affiliation:
Department of Management Science, Strathclyde Business School, University of Strathclyde, Glasgow, United Kingdom
Wanrudee Isaranuwatchai
Affiliation:
Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
Yot Teerawattananon
Affiliation:
Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, ThailandSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
Chris Painter*
Affiliation:
Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
*
*Author for correspondence: Chris Painter, E-mail: chris.painter@me.com
Rights & Permissions [Opens in a new window]

Abstract

Objectives

Health technology assessment (HTA) plays a central role in the coverage and reimbursement decision-making process for public health expenditure in many countries, including Thailand. However, there have been few attempts to quantitatively understand the benefits of using HTA to inform resource allocation decisions. The objective of this research was to simulate the expected net monetary benefit (NMB) from using HTA-based decision criteria compared to a first-come, first-served (FCFS) approach using data from Thailand.

Methods

A previously published simulation model was adapted to the Thai context which aimed to simulate the impact of using different decision-making criteria to adopt or reject health technologies for public reimbursement. Specifically, the simulation model provides a quantitative comparison between an HTA-based funding rule and a counterfactual (FCFS) funding rule to make decisions on which health technologies should be funded. The primary output of the model was the NMB of using HTA-based decision criteria compared to the counterfactual approach. The HTA-based decision rule in the model involved measuring incremental cost-effectiveness ratios against a cost-effectiveness threshold. The counterfactual decision rule was a FCFS (random) selection of health technologies.

Results

The HTA-based decision rule was associated with a greater NMB compared to the counterfactual. In the investigated analyses, the NMB ranged from THB24,238 million (USD725 million) to THB759,328 million (USD22,719 million). HTA-based decisions led to fewer costs, superior health outcomes (more quality-adjusted life-years).

Conclusions

The results support the hypothesis that HTA can provide health and economic benefits by improving the efficiency of resource allocation decision making.

Information

Type
Policy
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press
Figure 0

Figure 1.Flow diagram showing screening, identification, eligibility, and inclusion of health technology assessment reports for data extraction. HTA, health technology assessment; NLEM, National list of essential medicines; UCBP, universal coverage benefit package.

Figure 1

Table 1.Characteristics of Included HTA Reports

Figure 2

Figure 2.Scatter plot of incremental costs and incremental quality-adjusted life-years for included Thai health technology assessment appraisals. USD1 = THB33.4231.

Figure 3

Table 2.Model Results

Figure 4

Figure 3.Box plots of incremental QALY gains and incremental costs (Thai Baht) for explored HTA and FCFS scenarios. (A,B) Budget limit analysis. (C,D) Technology limit analysis. FCFS, first-come, first-served; HTA, health technology assessment; QALY, quality-adjusted life-year. USD1 = THB33.4231.

Supplementary material: PDF

Kingkaew et al. supplementary material

Kingkaew et al. supplementary material

Download Kingkaew et al. supplementary material(PDF)
PDF 342.1 KB